Top Markets
Coin of the day
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Classifica tra le azioni #100
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations... Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
Prezzo delle azioni
$150.78
Ultima sincronizzazione: 2026-09-18
Capitalizzazione di mercato
$187.20B
Variazione (1 giorno)
-0.08%
Variazione (1 anno)
32.15%
Paese
US
Scambia Gilead Sciences, Inc. (GILD)

Categoria

Storico del prezzo dell'azione per Gilead Sciences, Inc. (GILD)
Prezzo di chiusura più alto: $148.05 il 2026-09-01

Prezzo di chiusura più basso: $0.68 il 1992-01-01
Storico del prezzo dell'azione di Gilead Sciences, Inc. dal 1992 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) 7.70%
2025 32.61%
2024 15.91%
2023 -8.13%
2022 21.80%
2021 20.36%
2020 -10.67%
2019 1.05%
2018 -11.26%
2017 0.81%
2016 -28.48%
2015 2.18%
2014 36.94%
2013 97.77%
2012 89.46%
2011 6.00%
2010 -17.53%
2009 -5.59%
2008 2.32%
2007 41.64%
2006 23.63%
2005 49.13%
2004 22.34%
2003 58.83%
2002 9.37%
2001 62.17%
2000 85.80%
1999 26.99%
1998 -1.76%
1997 35.46%
1996 -4.73%
1995 201.99%
1994 -24.84%
1993 -22.36%
1992 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$1.15K 53.22%
US
$269.75 53.10%
US
$263.75 18.56%
US
$474.96 36.76%
CH
$146.40 79.61%
US